Zomedica Corp. (AMEX: ZOM) Emerges As Guiding Light For Investors

Zomedica Corp. (AMEX:ZOM) currently has a daily average trading volume of 3.83M but it saw 5536278 shares traded on Thursday. With a market cap of 182.21M USD, stock’s current market price of $0.19 came falling about -4.43 while comparing to the previous closing price of $0.20. In past 52 weeks, the stock remained buoying in the range of price level as high as $0.41 and as low as $0.15. In the recent trading on the day, stock has struck highest price mark of $0.20 while lowest mark touched by it was $0.19.

Taking a look at 20-day trading activity of Zomedica Corp. (ZOM) gives us an average price of $0.2034, while its current price level is -53.66% below from 52-week high level whereas it is 26.67% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.2070 while that of 200 days or SMA-200 reads an average of $0.2275. A closer look into the stock’s movement over the week reveals that its volatility is standing at 3.08% during that period while stretching the period over a month that increases to 3.98%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 39.26 which implies that the stock is in neutral territory.

Zomedica Corp. (ZOM)’s stock is currently under the radar of 1 analysts who are in consensus at a 12-month price target range of between $0.44 and $0.44 for company’s shares. The average price target assigned by the average number of analysts to a stock is a way to gauge worth of any stock in next 52 weeks. And in assigning price target to a stock, some analysts adopt a bearish approach by advocating lower-than-average price target which in this case is $0.44 while some adopt bullish approach by assigning higher-than-average price target which reads the price to top $0.44. Average price target assigned by them is $0.44 which highlights an upside potential of 56.82% for the stock over that period. And to attain the median price target of $0.44 assigned by those analysts, stock has to add about 56.82% of value to its current levels.

Data by FactSet Research shows that 1 analysts have issued their ratings for the stock. 0 of them are in opinions that stock is a Sell, while 0 are advising it as an Overweight. 1 analysts suggested the investors to Buy the stock while 0 advised them to Hold. Recommendations by all of those brokerages imply a consensus rating of Buy for the stock and that issued by Wall Street to investors is Moderate Buy.

Over the week, ZOM’s stock price is moving -5.28% down while it is -6.40% when we observe its performance for the past one month. Year-to-date it is 16.56% up and over the past year, the stock is showing a downside performance of -14.41%.

The latest quarterly earnings report issued by the company was for quarter ended 3/30/2023, when its quarterly earnings per share (EPS) of -$0.01 beaten by the consensus estimate of $0 for the same. For ZOM, analysts are forecasting an EPS-growth rate of 50.00% for current year and estimate for EPS growth in next year is 100.00%. In next quarter, company is expected to be making quarterly sales of $8.28 million as analysts are expecting the sales for current fiscal year at $31.12 million and seeing the company making $43.06 million in sales next year. Moreover, analysts are in estimates of $7.34 million for current-quarter revenue.

Currently, Zomedica Corp.’s total number of outstanding shares is 979.95M with 1.33% of that held by the insiders while 9.77% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -7.30% and return on equity (ROE) at -7.30%. Stock’s beta reads 0.96. Stock has a price to book (P/B) ratio of 0.70 while price to sale or P/S ratio amounts to 8.80. Its return on asset (ROA) is -7.00% on average.